Top

Published in:

01-08-2014 | Research Paper

Living in shear: platelets protect cancer cells from shear induced damage

Authors: Karl Egan, Niamh Cooke, Dermot Kenny

Published in: Clinical & Experimental Metastasis | Issue 6/2014

Abstract

Pharmacologically and genetically induced thrombocytopenia is associated with decreased metastasis, highlighting the importance of platelets in the bloodborne dissemination of cancer cells. It is frequently suggested that platelets support metastasis, in part, by protecting cancer cells from shear stress, a biomechanical force generated by blood flow. However, there is currently no evidence to support this hypothesis. To address this, we investigated the effect of shear stress on A2780 ovarian cancer cells in the presence and absence of platelets. Using a cone and plate viscometer, suspensions of A2780 cells with and without platelets were exposed to shear rates representing venous (200 s⁻¹) and arterial (1,500 s⁻¹) blood flow. Lactate dehydrogenase (LDH) release was used to quantify shear induced membrane damage. Both venous and arterial shear rates induced the release of LDH from A2780 cells, demonstrating their susceptibility to shear forces. In contrast, platelets released minimal levels of LDH in response to similar conditions. In the presence of platelets, there was a significant decrease in LDH release by A2780 cells under shear conditions, suggesting that platelets can confer protection against shear induced damage. The disruption of platelet–cancer cell interactions could increase the shear stress induced destruction of cancer cells in vivo.

Stone RL et al (2012) Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med 366(7):610–618PubMedCentralPubMedCrossRef

Ho-Tin-Noe B et al (2008) Platelet granule secretion continuously prevents intratumor hemorrhage. Cancer Res 68(16):6851–6858PubMedCentralPubMedCrossRef

Camerer E et al (2004) Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood 104(2):397–401PubMedCrossRef

Gasic GJ, Gasic TB, Stewart CC (1968) Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci USA 61(1):46–52PubMedCentralPubMedCrossRef

Jain S, Russell S, Ware J (2009) Platelet glycoprotein VI facilitates experimental lung metastasis in syngenic mouse models. J Thromb Haemost 7(10):1713–1717PubMedCrossRef

Jain S et al (2007) Platelet glycoprotein Ib alpha supports experimental lung metastasis. Proc Natl Acad Sci USA 104(21):9024–9028PubMedCentralPubMedCrossRef

Kim YJ et al (1998) P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci USA 95(16):9325–9330PubMedCentralPubMedCrossRef

Alonso-Escolano D et al (2004) Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins. Br J Pharmacol 141(2):241–252PubMedCentralPubMed

Jurasz P, Alonso-Escolano D, Radomski MW (2004) Platelet–cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation. Br J Pharmacol 143(7):819–826PubMedCentralPubMed

10.

Jurasz P et al (2003) Matrix metalloproteinase-2 contributes to increased platelet reactivity in patients with metastatic prostate cancer: a preliminary study. Thromb Res 112(1–2):59–64PubMedCrossRef

11.

Jurasz P et al (2001) Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide. Cancer Res 61(1):376–382PubMed

12.

Karpatkin S, Ambrogio C, Pearlstein E (1988) The role of tumor-induced platelet aggregation, platelet adhesion and adhesive proteins in tumor metastasis. Prog Clin Biol Res 283:585–606PubMed

13.

Karpatkin S et al (1988) Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. J Clin Invest 81(4):1012–1019PubMedCentralPubMedCrossRef

14.

Karpatkin S et al (1982) Platelet aggregating material (PAM) of two virally-transformed tumors: SV3T3 mouse fibroblast and PW20 rat renal sarcoma. Role of cell surface sialylation. Prog Clin Biol Res 89:445–477PubMed

15.

Nieswandt B et al (1999) Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 59(6):1295–1300PubMed

16.

Zheng S et al (2009) Platelets and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity. Cancer Sci 100(5):859–865PubMedCrossRef

17.

Palumbo JS et al (2005) Platelets and fibrin (ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 105(1):178–185PubMedCrossRef

18.

Placke T et al (2011) Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells. Cancer Res 72(2):440–448PubMedCrossRef

19.

Placke T, Kopp HG, Salih HR (2011) Modulation of natural killer cell anti-tumor reactivity by platelets. J Innate Immun 3(4):374–382PubMedCrossRef

20.

Labelle M, Begum S, Hynes RO (2011) Direct signaling between platelets and cancer cells induces an epithelial–mesenchymal-like transition and promotes metastasis. Cancer Cell 20(5):576–590PubMedCentralPubMedCrossRef

21.

Lowe KL, Navarro-Nunez L, Watson SP (2012) Platelet CLEC-2 and podoplanin in cancer metastasis. Thromb Res 129(Suppl 1):S30–S37PubMedCrossRef

22.

Dvoretsky PM et al (1988) Distribution of disease at autopsy in 100 women with ovarian cancer. Hum Pathol 19(1):57–63PubMedCrossRef

23.

Egan K et al (2011) Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells. PLoS ONE 6(10):e26125PubMedCentralPubMedCrossRef

24.

Nylander S et al (2004) Synergistic action between inhibition of P2Y12/P2Y1 and P2Y12/thrombin in ADP- and thrombin-induced human platelet activation. Br J Pharmacol 142(8):1325–1331PubMedCentralPubMed

25.

Cattaneo M et al (1993) Shear-induced platelet aggregation is potentiated by desmopressin and inhibited by ticlopidine. Arterioscler Thromb 13(3):393–397PubMedCrossRef

26.

Berezovskaya O et al (2005) Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells. Cancer Res 65(6):2378–2386PubMedCrossRef

27.

Rhim AD et al (2012) EMT and dissemination precede pancreatic tumor formation. Cell 148(1–2):349–361PubMedCentralPubMedCrossRef

28.

Zong W (2006) Thompson, CB, Necrotic death as a cell fate. Genes Dev 20(1):1–15PubMedCrossRef

29.

Coleman ML et al (2001) Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat Cell Biol 3(4):339–345PubMed

30.

Lawler K et al (2006) Mobility and invasiveness of metastatic esophageal cancer are potentiated by shear stress in a ROCK- and Ras-dependent manner. Am J Physiol Cell Physiol 291(4):C668–C677PubMed

31.

Lawler K et al (2009) Shear stress induces internalization of E-cadherin and invasiveness in metastatic oesophageal cancer cells by a Src-dependent pathway. Cancer Sci 100(6):1082–1087PubMedCrossRef

32.

Qazi H, Shi ZD, Tarbell JM (2011) Fluid shear stress regulates the invasive potential of glioma cells via modulation of migratory activity and matrix metalloproteinase expression. PLoS ONE 6(5):e20348PubMedCentralPubMedCrossRef

33.

Chang SF et al (2008) Tumor cell cycle arrest induced by shear stress: roles of integrins and Smad. Proc Natl Acad Sci USA 105(10):3927–3932PubMedCentralPubMedCrossRef

34.

Brooks DE (1984) The biorheology of tumor cells. Biorheology 21(1–2):85–91PubMed

35.

Wei X et al (2005) Real-time detection of circulating apoptotic cells by in vivo flow cytometry. Mol Imaging 4(4):415–416PubMedCentralPubMed

36.

Wyckoff JB et al (2000) A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. Cancer Res 60(9):2504–2511PubMed

37.

Corti R et al (2004) Evolving concepts in the triad of atherosclerosis, inflammation and thrombosis. J Thromb Thrombolysis 17(1):35–44PubMedCrossRef

38.

Fuster V et al (2005) Atherothrombosis and high-risk plaque: part I: evolving concepts. J Am Coll Cardiol 46(6):937–954PubMedCrossRef

39.

Malek AM, Alper SL, Izumo S (1999) Hemodynesamic shear stress and its role in atherosclerosis. JAMA 282(21):2035–2042PubMedCrossRef

40.

Cunningham KS, Gotlieb AI (2005) The role of shear stress in the pathogenesis of atherosclerosis. Lab Invest 85(1):9–23PubMedCrossRef

41.

Lawler K et al (2004) Shear stress modulates the interaction of platelet-secreted matrix proteins with tumor cells through the integrin alphavbeta3. Am J Physiol Cell Physiol 287(5):C1320–C1327PubMed

42.

Dupire J, Socol M, Viallat A (2012) Full dynamics of a red blood cell in shear flow. Proc Natl Acad Sci USA 109(51):20808–20813PubMedCentralPubMedCrossRef

43.

Trabert B et al (2014) Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. J Natl Cancer Inst 106(2):djt431PubMedCrossRef

Title: Living in shear: platelets protect cancer cells from shear induced damage
Authors: Karl Egan
Niamh Cooke
Dermot Kenny
Publication date: 01-08-2014
Publisher: Springer Netherlands
Published in: Clinical & Experimental Metastasis / Issue 6/2014
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI: https://doi.org/10.1007/s10585-014-9660-7

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2014

Hyaluronan expression as a significant prognostic factor in patients with malignant peripheral nerve sheath tumors

Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs

ADRM1 gene amplification is a candidate driver for metastatic gastric cancers

FN14 expression correlates with MET in NSCLC and promotes MET-driven cell invasion

Diet modulation is an effective complementary agent in preventing and treating breast cancer lung metastasis

COX2 expression in neuroblastoma increases tumorigenicity but does not affect cell death in response to the COX2 inhibitor celecoxib

Keynote webinar | Spotlight on antibody–drug conjugates in cancer